Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients
E-SEP
e-SEP Cognition: Effectiveness of a Remediation Program Via a "Serious Game" on the Cognitive Functions of Multiple Sclerosis Patients: Controlled, Randomized, Multicentric Trial
1 other identifier
interventional
150
1 country
6
Brief Summary
The main goal of this study is to assess the effectiveness of a cognitive remediation program based on a "serious game" on the information processing speed evolution and the process of learning via episodic memory in multiple sclerosis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable multiple-sclerosis
Started Oct 2021
Longer than P75 for not_applicable multiple-sclerosis
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2020
CompletedFirst Posted
Study publicly available on registry
January 5, 2021
CompletedStudy Start
First participant enrolled
October 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 4, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
ExpectedSeptember 4, 2025
September 1, 2025
4.5 years
December 16, 2020
September 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in the California Verbal Learning Test (CVLT)
The California Verbal Learning Test (CVLT) begins with the examiner reading a list of 16 words. Patients listen to the list and report as many of the items as possible.
Change from baseline at 4 and 10 months
Change in the Brief Visuo-spatial Memory Test (BVMT)
In the Brief Visuospatial/lMemory Test six abstract designs are presented for 10 sec. The display is removed from view and patients render the stimuli via pencil on paper manual responses. Each design receives from 0 to 2 points representing accuracy and location. Thus, scores range from 0 to 12.
Change from baseline at 4 and 10 months
Change in the Symbol Digit Modalities Test (SDMT)
The Symbol Digit Modalities Test (SDMT) presents a series of nine symbols, each paired with a single digit in a key at the top of a standard sheet of paper. Patients are asked to voice the digit associated with each symbol as rapidly as possible for 90 sec. There is a single outcome measure: the number correct.
Change from baseline at 4 and 10 months
Secondary Outcomes (20)
Change in the Auditory-verbal spans in direct or reverse order
Change from baseline at 4 and 10 months
Change in the Stroop Color-Word Test
Change from baseline at 4 and 10 months
Change in the Trail Making Test
Change from baseline at 4 and 10 months
Change in the Categorical and phonemic verbal fluency test
Change from baseline at 4 and 10 months
Change in the Tower of London test
Change from baseline at 4 and 10 months
- +15 more secondary outcomes
Study Arms (2)
Remediation program via a "serious game"
EXPERIMENTALClassic care (recommended by the French Haute Autorité de Santé) accompanied by cognitive remediation by "serious game"
Classic care (French Haute Autorité de Santé)
PLACEBO COMPARATORClassic care (recommended by French Haute Autorité de Santé)
Interventions
The serious game is accessible via an online platform, on a tablet: 4 20-minutes activities sessions per week must be carried out. The program format in the serious game form makes possible to simultaneously understand a large number of cognitive functions.
The control group patients will follow the care they need, according to the HAS recommendations. Non-specific cognitive activities notebooks will be provided to them. They will be instructed to perform the 4 20-minutes sessions per week for 4 months.
Eligibility Criteria
You may qualify if:
- Relapsing-remitting or progressive multiple sclerosis people defined according to Mc Donald's criteria revised in 2005
- Age between ≥ 18 and ≤ 65 years old
- Cognitive complaint, with at least one deficient score at the initial neuropsychological examination (\<5th percentile of the reference group), one of the scores of which concerns at least one BICAMS test
- Have not had a definite relapse for at least 6 weeks
- Be at least 4 weeks away from a corticosteroid bolus
- Lack of neuroleptic treatment
- Patient with an Internet connection
- Signed informed consent
You may not qualify if:
- Severe cognitive deficit defined by obtaining a deficit score in more than six cognitive processes at the initial neuropsychological assessment.
- Neuropsychological care
- Inability to receive oral and written information
- Inability to use the software (due in particular to motor and / or sensory difficulties),
- Neurological or psychiatric comorbidity, other than MS and anxiodepressive syndrome
- Patient with severe anxiodepressive syndrome (BDI\> 27)
- Participation in an interventional study on cognitive functions
- Patient under legal protection, guardianship or curatorship
- Pregnant or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
CH Arras
Arras, Hauts-de-France, 62000, France
CH LENS
Lens, Hauts-de-France, 62300, France
CHRU
Lille, Hauts-de-France, 59000, France
Saint Vincent hospital
Lille, Hauts-de-France, 59000, France
Saint-Philibert hospital
Lomme, Nord, 59462, France
Charles Nicolle Hospital
Rouen, Normandy, 76000, France
Related Publications (1)
Lenne B, Degraeve B, Davroux J, Norberciak L, Kwiatkowski A, Donze C. Improving cognition in people with multiple sclerosis: study protocol for a multiarm, randomised, blinded trial of multidomain cognitive rehabilitation using a video-serious game (E-SEP cognition). BMJ Neurol Open. 2023 Nov 27;5(2):e000488. doi: 10.1136/bmjno-2023-000488. eCollection 2023.
PMID: 38033375DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bruno Lenne
Hôpital Saint-Vincent de Paul
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- This is a blinded study for neuropsychological assessment.
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2020
First Posted
January 5, 2021
Study Start
October 8, 2021
Primary Completion
April 4, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
September 4, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share